Allworth Financial’s Soleno Therapeutics SLNO Stock Holding History

Allworth Financial’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-26	Closed	-$871	–	5377
2026 Q1	$871	Buy	26 +15	+136%	+$588	﹤0.01%	4608
2025 Q4	$510	Sell	11 -9	-45%	-$493	﹤0.01%	4521
2025 Q3	$1.35K	Sell	20 -40	-67%	-$2.97K	﹤0.01%	4166
2025 Q2	$5.03K	Buy	60 +46	+329%	+$3.44K	﹤0.01%	3255
2025 Q1	$1.04K	Buy	14 +9	+180%	+$438	﹤0.01%	3450
2024 Q4	$243	Hold	5	–	–	﹤0.01%	3749
2024 Q3	$253	Hold	5	–	–	﹤0.01%	3555
2024 Q2	$235	Buy	+5	New	+$212	﹤0.01%	3533

Allworth Financial's SLNO Position: Q2 2026 in Review

Allworth Financial sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 26 shares — an estimated $871 sold.

Allworth Financial first reported a position in SLNO in Q2 2024 and held it in 8 quarters. The position peaked at $5.03K in Q2 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Allworth Financial reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Allworth Financial sold 26 Soleno Therapeutics shares in Q2 2026, an estimated $871.
Allworth Financial first reported a position in Soleno Therapeutics in Q2 2024 and held it in 8 quarters.
Allworth Financial's Soleno Therapeutics position peaked at $5.03K in Q2 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.